The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods

被引:166
作者
de Graaf, Ron [1 ]
Ten Have, Margreet [1 ]
van Dorsselaer, Saskia [1 ]
机构
[1] Netherlands Inst Mental Hlth & Addict, NL-3521 VS Utrecht, Netherlands
关键词
prospective general population study; mood disorder; anxiety disorder; substance use disorder; impulse-control disorder; NATIONAL COMORBIDITY SURVEY; SUBSTANCE USE DISORDERS; INTERNATIONAL DIAGNOSTIC INTERVIEW; MAJOR DEPRESSIVE EPISODE; IV PERSONALITY-DISORDERS; R PSYCHIATRIC-DISORDERS; ALCOHOL-USE DISORDERS; DRUG-USE DISORDERS; CARE SERVICE USE; GENERAL-POPULATION;
D O I
10.1002/mpr.317
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The psychiatric epidemiological population study NEMESIS-2 (Netherlands Mental Health Survey and Incidence Study-2) replicates and expands the first Netherlands Mental Health Survey and Incidence Study (NEMESIS-1) conducted from 1996 to 1999. The main objectives of the new study are to provide up-to-date figures on the prevalence, incidence, course and consequences of mental disorders, and to study trends in mental disorders and service use, with the use of a new sample. New topics not included in NEMESIS-1 were added, e. g. impulse-control disorders, and genetic correlates of mental disorders through gathering DNA from saliva samples. This paper gives an overview of the design of NEMESIS-2, especially of its recently completed first wave. NEMESIS-2 is a prospective study among Dutch-speaking subjects aged 18-64 years from the general Dutch population. Its baseline wave included 6646 subjects. Three waves are planned with three year-intervals between the waves. A multistage, stratified random sampling procedure was applied. The baseline wave of NEMESIS-2 was performed between November 2007 and July 2009. Face-to-face interviews were administered with the Composite International Diagnostic Interview (CIDI) 3.0. The response rate was 65.1%, and 76.4% of the respondents donated saliva. The sample was reasonably nationally representative, but younger subjects were somewhat underrepresented. In conclusion, we were able to build a comprehensive dataset of good quality, permitting several topics to be studied in the future. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:125 / 141
页数:17
相关论文
共 90 条
[21]   Alcohol abuse and dependence criteria as predictors of a chronic course of alcohol use disorders in the general population [J].
De Bruijn, C ;
Van den Brink, W ;
De Graaf, R ;
Vollebergh, WAM .
ALCOHOL AND ALCOHOLISM, 2005, 40 (05) :441-446
[22]   Psychiatric and sociodemographic predictors of attrition in a longitudinal study - The Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
de Graaf, R ;
Bijl, RV ;
Smit, F ;
Ravelli, A ;
Vollebergh, WAM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (11) :1039-1047
[23]   Predictors of first incidence of DSM-III-R psychiatric disorders in the general population: findings from the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
Bijl, RV ;
Ravelli, A ;
Smit, F ;
Vollebergh, WAM .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (04) :303-313
[24]   Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study [J].
de Graaf, R ;
Bijl, RV ;
ten Have, M ;
Beekman, ATF ;
Vollebergh, WAM .
JOURNAL OF AFFECTIVE DISORDERS, 2004, 82 (03) :461-467
[25]   Negative and positive participant responses to the composite international diagnostic interview - Results of the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
ten Have, M ;
van Dorsselaer, S ;
Schoemaker, C ;
Vollebergh, WAM .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2004, 39 (07) :521-527
[26]   Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - Findings from the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
Bijl, RV ;
Spijker, J ;
Beekman, ATF ;
Vollebergh, WAM .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2003, 38 (01) :1-11
[27]   Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
Bijl, RV ;
Smith, F ;
Vollebergh, WAM ;
Spijker, J .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04) :620-629
[28]   Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys [J].
Demyttenaere, K ;
Bruffaerts, R ;
Posada-Villa, J ;
Gasquet, I ;
Kovess, V ;
Lepine, JP ;
Angermeyer, MC ;
Bernert, S ;
de Girolamo, G ;
Morosini, P ;
Polidori, G ;
Kikkawa, T ;
Kawakami, N ;
Ono, Y ;
Takeshima, T ;
Uda, H ;
Karam, EG ;
Fayyad, JA ;
Karam, AN ;
Mneimneh, ZN ;
Medina-Mora, ME ;
Borges, G ;
Lara, C ;
de Graaf, R ;
Ormel, J ;
Gureje, O ;
Shen, YC ;
Huang, YQ ;
Zhang, MY ;
Alonso, J ;
Haro, JM ;
Vilagut, G ;
Bromet, EJ ;
Gluzman, S ;
Webb, C ;
Kessler, RC ;
Merikangas, KR ;
Anthony, JC ;
Von Korff, MR ;
Wang, PS ;
Alonso, J ;
Brugha, TS ;
Aguilar-Gaxiola, S ;
Lee, S ;
Heeringa, S ;
Pennell, BE ;
Zaslavsky, AM ;
Ustun, TB ;
Chatterji, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (21) :2581-2590
[29]   Understanding mental health treatment in persons without mental diagnoses - Results from the National Comorbidity Survey replication [J].
Druss, Benjamin G. ;
Wang, Philip S. ;
Sampson, Nancy A. ;
Olfson, Mark ;
Pincus, Harold A. ;
Wells, Kenneth B. ;
Kessler, Ronald C. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (10) :1196-1203
[30]  
DuPaul GJ, 1998, ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation